PERSPECTIVE
Accepted on 05 Dec 2025
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- The Differentiation and Reprogramming of Tumor-Associated Myeloid Cells and Therapeutic Strategies for Cancer Immunotherapy
The Differentiation and Reprogramming of Tumor-Associated Myeloid Cells and Therapeutic Strategies for Cancer Immunotherapy
2,191
Total downloads
8,816
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 02 Dec 2025
Gemcitabine-cisplatin chemotherapy plus anti-PD-L1 therapy reinvigorates antitumor immune response by reprogramming the intrahepatic cholangiocarcinoma microenvironment
doi 10.3389/fimmu.2025.1666393
- 241 views
ORIGINAL RESEARCH
Published on 15 Apr 2025
Bezafibrate-driven mitochondrial targeting enhances antitumor immunity and prevents lung cancer via CD8+ T cell infiltration and MDSC reduction
doi 10.3389/fimmu.2025.1539808
- 2,854 views
- 3 citations
ORIGINAL RESEARCH
Published on 13 Sep 2024
Radiation immunodynamics in patients with glioblastoma receiving chemoradiation
doi 10.3389/fimmu.2024.1438044
- 3,488 views
- 3 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Other participating journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: